Cyclophosphamide

A$0.00

Cyclophosphamide is a chemotherapy medicine used to treat certain cancers and some serious immune conditions. It works by slowing down or stopping the growth of fast-growing cells. You may receive it by injection or by mouth, depending on your treatment plan. Common side effects can include nausea, tiredness, loss of appetite, and increased risk of infection or bleeding. Your doctor will monitor blood counts regularly during treatment.

Cyclophosphamide (Overview)

Cyclophosphamide is a chemotherapy medicine used to treat certain cancers and a range of immune-mediated conditions. It works by slowing or stopping the growth of rapidly dividing cells, including some cancer cells. It is also used in selected autoimmune diseases where immune activity needs to be reduced.

This page is designed to be patient-friendly and to provide clear general information about how cyclophosphamide works, how it is used, and what to expect. Individual treatment plans can vary substantially depending on the condition being treated, your test results, and your overall health.


Basic product information

Item Information
Generic name Cyclophosphamide
Medicine type Chemotherapy (alkylating agent); immunosuppressant
Common formulations Tablets (oral); also available as injection in clinical practice (varies by product)
Availability Distributed through Australian medicines channels; supply may depend on brand/formulation
Key safety considerations Bone marrow suppression, risk of infection, bladder/urinary toxicity (hemorrhagic cystitis), fertility effects, and nausea

How cyclophosphamide works (mechanism of action)

Cyclophosphamide is a prodrug. After it enters the body, it is converted mainly in the liver into active metabolites. These metabolites then damage DNA in rapidly dividing cells by forming cross-links that interfere with DNA replication and cell division.

Because many cancer cells and activated immune cells divide quickly, cyclophosphamide can reduce tumor growth and also calm certain immune processes. Different cancers and autoimmune diseases respond differently, which is why dosing schedules and combinations with other medicines vary.

  • DNA alkylation: Active metabolites add chemical groups to DNA
  • Cell cycle disruption: Damage prevents successful cell division
  • Immunosuppression: Reduces activity of certain immune cells

Pharmacokinetics (how the body handles it)

Cyclophosphamide is processed in the body through absorption (for oral forms), liver metabolism, distribution into tissues, and eventual elimination through the kidneys.

  • Absorption: Oral cyclophosphamide is absorbed through the gastrointestinal tract; specific exposure can vary by formulation and individual factors.
  • Metabolism: Mainly hepatic metabolism converts it into active and less active metabolites.
  • Distribution: Active metabolites circulate in the bloodstream and reach tissues including the bone marrow and lymphatic system.
  • Elimination: Metabolites are cleared largely via the kidneys and into urine.
  • Bladder exposure: A metabolite related to urinary toxicity can concentrate in urine, which is why bladder protection strategies are important in practice.

Your clinician may check blood counts and sometimes urine-related symptoms to help manage risks. Age, kidney/liver function, other medicines, and treatment goals can all affect overall exposure and risk.


Typical uses (indications)

Cyclophosphamide is used in multiple settings. Your treatment plan depends on the underlying diagnosis, disease severity, and response to other therapies.

Oncology (cancers)

Examples of cancer contexts where cyclophosphamide may be used include:

  • Certain lymphomas
  • Some leukemias (often as part of multi-agent regimens)
  • Breast and other cancers in combination protocols
  • Some conditioning regimens in hematology/oncology (institution-specific practice)

Immune-mediated conditions (autoimmune diseases)

In selected autoimmune and inflammatory conditions, cyclophosphamide may be used when disease is severe and other options are insufficient. Use is typically specialist-led and involves careful monitoring.

  • Severe vasculitis (e.g., some forms of ANCA-associated vasculitis)
  • Certain severe connective tissue diseases (specialist assessment required)
  • Other aggressive immune-mediated conditions in defined treatment scenarios

Because indications differ by country, product, and guideline updates, always check the intended use for your specific medicine and regimen.


How to take cyclophosphamide (timing and practical use)

Timing and administration depend on the dosing schedule chosen by your treating team and the formulation you receive (for example, daily dosing vs intermittent cycles). For oral tablets, consistent timing is generally important.

General timing principles

  • Follow your schedule exactly: Your dose may be given in cycles or on specific days.
  • Take at the same time each day: If you are on daily dosing, choose a time that is easy to remember.
  • Do not change the dose: Dose adjustments should be clinician-led based on blood counts and side effects.
  • Missed doses: If you miss a dose, do not double up. Contact your healthcare team or pharmacist for advice.

Food and administration

Cyclophosphamide tablets may be taken with or without food depending on the specific product instructions. If nausea occurs, taking the medicine with food may help some people. However, always follow the instructions given with your particular brand.

  • Try to maintain a consistent routine: If you take it with food one day, try to do the same going forward (unless advised otherwise).
  • Hydration matters: Adequate fluid intake supports comfort and helps reduce the concentration of metabolites in urine (unless you have been told to restrict fluids).
  • Handling precautions: If tablets are being managed by caregivers, they should be handled carefully according to local safety guidance for cytotoxic medicines.

Food interactions

Cyclophosphamide has fewer direct, well-known dietary interactions than some other medicines, but individual metabolism can be influenced by liver enzyme activity and overall health.

Key practical food considerations:

  • Grapefruit and bitter orange: Some medicines are affected by compounds in grapefruit. There isn’t one universal rule for cyclophosphamide, but it’s sensible to avoid or confirm with your pharmacist if you commonly use grapefruit products.
  • High-alcohol use and dehydration: Alcohol can worsen dehydration and side effects; maintaining hydration is important.
  • Stomach upset: If you feel nauseated, smaller meals and bland foods may help. Ask about anti-nausea medicines if needed.

If you are using herbal supplements or high-dose vitamins, check with your pharmacist—some supplements can affect liver metabolism.


Alcohol interactions

It is generally recommended to avoid or limit alcohol during treatment with cyclophosphamide, because alcohol may:

  • Increase nausea, fatigue, and dizziness
  • Impact liver metabolism (important because cyclophosphamide is metabolised in the liver)
  • Worsen dehydration, potentially increasing urinary irritation
  • Increase risk of infections indirectly by affecting immune function and nutritional status

If you are unsure whether occasional alcohol is appropriate for you, discuss it with your treating team. In many circumstances, the safer approach is to avoid alcohol while on therapy and until your clinician confirms it is appropriate.


Medicine interactions (important examples)

Cyclophosphamide can interact with other medicines that affect liver enzymes, kidney function, or blood cell counts. Interactions may increase side effects or reduce effectiveness.

Common categories to discuss with your pharmacist:

  • Other medicines that suppress the bone marrow: This can increase infection and bleeding risk.
  • Live vaccines: Vaccination timing and type should be coordinated with your clinician.
  • Strong liver enzyme inducers or inhibitors: These may change cyclophosphamide metabolism.
  • Medicines affecting bleeding risk: Especially if platelet counts become low.
  • Medicines that affect urination/bladder function: Discuss any urinary symptoms promptly.

Always bring a complete list of all medicines, including over-the-counter products and herbal remedies, to your pharmacy or appointment. If you have started a new medicine since beginning cyclophosphamide, inform your healthcare team.


Dosing (general guidance)

Cyclophosphamide dosing varies by indication, treatment goal, regimen, and your blood counts. It may be prescribed as a fixed dose per body surface area or based on weight and clinical factors. Schedules may include daily dosing, intermittent dosing, or combinations with other agents.

What typically influences dose selection:

  • Your diagnosis and treatment intent
  • Body size (often used to calculate dosing)
  • Kidney and liver function
  • Baseline blood counts
  • Prior treatments (including previous chemotherapy)
  • Planned combination therapy

Because dosing is complex and closely monitored, the information below is general and not a substitute for your individual regimen.

Monitoring that commonly accompanies dosing

  • Full blood counts: To track white blood cells, neutrophils, hemoglobin, and platelets
  • Kidney function: Especially when urinary toxicity is a concern
  • Liver function: For general safety and metabolism-related issues
  • Urine symptoms: Pain, burning, blood in urine, or reduced urine output

Your clinician may delay the next dose or adjust dosing based on results and side effects.


Safety profile and side effects

Cyclophosphamide has important risks. Many side effects are manageable with supportive care, monitoring, and dose adjustments. It’s crucial to know which symptoms require urgent attention.

Common side effects

  • Nausea and vomiting
  • Fatigue
  • Hair thinning or hair loss (varies with regimen)
  • Loss of appetite
  • Mouth sores (in some cases)
  • Infections (risk increases when white blood cells are low)

Serious risks

  • Bone marrow suppression: Low white blood cells can lead to serious infection. Low platelets can increase bleeding risk.
  • Urinary bladder toxicity (hemorrhagic cystitis): Symptoms can include burning pain when urinating, frequent urination, or blood in the urine.
  • Infertility and fertility changes: Cyclophosphamide may affect fertility in men and women. Discuss fertility preservation options early if relevant.
  • Increased risk of secondary malignancies: This risk is related to cumulative exposure and individual factors.
  • Cardiac toxicity: Can occur rarely depending on dose and regimen; symptoms should be evaluated promptly.
  • Allergic reactions: Seek urgent medical help if you develop swelling of the face, trouble breathing, or widespread rash.

When to seek urgent medical attention

Contact emergency services or seek urgent care if you experience:

  • Fever (especially if above your treatment team’s threshold)
  • Signs of infection: chills, severe sore throat, persistent cough, burning urination
  • Blood in urine, severe bladder pain, or inability to urinate
  • Unusual bruising or bleeding
  • Severe shortness of breath, chest pain, or fainting
  • Severe allergic symptoms (swelling, wheezing, or hives with breathing difficulty)

Practical use tips (help you manage treatment day-to-day)

  • Hydrate as advised: Many bladder-protection strategies include adequate fluid intake. If you have heart failure, kidney disease, or a fluid restriction plan, follow your clinician’s instructions.
  • Use urinary monitoring: Report burning, urgency, or blood in urine promptly.
  • Prevent infection where possible: Good hand hygiene, avoiding sick contacts, and reporting fever quickly can be vital.
  • Oral care: If you develop mouth sores, use gentle brushing, soft toothbrushes, and ask your healthcare team about mouthwashes.
  • Manage nausea early: Anti-nausea medicines may be prescribed; take them as directed before symptoms become severe.
  • Keep a symptom diary: Track side effects such as nausea, fatigue, urinary symptoms, and appetite. This helps you and your clinician respond quickly.
  • Lab appointment readiness: Blood tests are often scheduled before or between doses. Arrive early and inform staff about upcoming doses.

Because cyclophosphamide affects the immune system and can reduce blood counts, it’s also important to plan daily activities around energy levels and monitor for infections.


Alternative options

Alternatives depend strongly on whether cyclophosphamide is being used for cancer therapy or an autoimmune/inflammatory condition. Your clinician chooses options based on disease characteristics, prior treatments, and your overall health.

Possible alternatives in oncology

  • Other chemotherapy agents used in combination regimens
  • Targeted therapies or immunotherapies, where appropriate
  • Radiation therapy (sometimes used alongside systemic treatment)
  • In selected hematology settings, specialist protocols may include different conditioning medicines

Possible alternatives in autoimmune disease

  • Corticosteroids (for induction or flare control)
  • Other immunosuppressants (e.g., medicines targeting immune pathways such as antimetabolites or biologic agents, depending on diagnosis)
  • Adjunct therapies to control symptoms and prevent organ damage

Don’t stop or replace cyclophosphamide without medical guidance. If you have concerns about side effects, discuss them early—sometimes dose adjustments, supportive medicines, or regimen changes can help.


Market and legal context for Australia

In Australia, cancer medicines and other systemic therapies are regulated to ensure appropriate supply, safe prescribing, and monitoring. Cyclophosphamide is included within Australia’s medicines framework and is supplied through authorised channels.

  • Regulated access: Medicines like cyclophosphamide are tightly controlled due to their potency and safety profile.
  • Specialist oversight: Use often requires specialist assessment and ongoing monitoring (blood tests, symptom checks).
  • Pharmacovigilance: Serious adverse effects should be reported through appropriate healthcare pathways.

Supply availability can vary by formulation and brand. Your pharmacy can confirm availability and expected dispatch times once the required medicine details are provided.


Recent guidance and monitoring considerations

Guidance in oncology and immunology evolves as new evidence becomes available. In general, current practice commonly emphasises:

  • Close blood count monitoring to reduce the risk of severe infection
  • Bladder toxicity prevention strategies in regimens where urinary metabolites pose risk
  • Infection prevention planning (including timing of vaccinations and prompt fever management)
  • Fertility and reproductive counselling before treatment when possible
  • Medication reconciliation to reduce avoidable drug interactions

Your treating team may also follow local hospital protocols and evidence-based treatment guidelines for the specific condition you’re being treated for.


Delivery and availability (online pharmacy information)

Availability for cyclophosphamide may depend on the specific formulation (for example, tablet strength) and current stock levels. Online pharmacies typically:

  • Confirm product and strength before dispatch
  • Provide expected delivery timeframes based on Australian delivery services
  • Package medicines securely to protect contents during transport

Delivery processes vary by region and supplier. If you require a particular brand or strength, it’s helpful to check with your pharmacy during ordering so the correct product is supplied.


Storage and handling

  • Store as directed: Follow the packaging instructions for temperature and protection from light/moisture.
  • Keep out of reach of children: Cytotoxic medicines must be stored safely.
  • Follow medication disposal instructions: Return unused medicine through recommended disposal channels when advised.
  • Handling cytotoxic tablets: If tablets are being handled by someone else, they should use appropriate precautions as advised by pharmacy staff or product instructions.

FAQ

1) What is cyclophosphamide used for?

Cyclophosphamide is used for certain cancers and, in selected severe autoimmune or inflammatory conditions, to reduce immune activity. The exact use depends on the diagnosis and treatment regimen.

2) How long does cyclophosphamide take to work?

Many effects begin within days, but the overall response—such as tumour shrinkage or disease control—may take weeks and is evaluated through clinical assessments, imaging, and laboratory results.

3) Can I take cyclophosphamide with food?

Instructions can vary by product. In many cases, it may be taken with or without food; if nausea occurs, taking it with food can help. Always follow the instructions on your medicine label and the advice from your pharmacist.

4) What should I do if I miss a dose?

Do not double the dose. Contact your healthcare team or pharmacist for guidance, as the correct response depends on your dosing schedule and cycle timing.

5) Are blood tests necessary?

Yes. Cyclophosphamide commonly affects bone marrow, so blood tests (full blood counts and sometimes other labs) are used to monitor safety and guide treatment timing.

6) Why do people get urinary symptoms with cyclophosphamide?

Certain metabolites can irritate the bladder. Monitoring and prevention strategies are used in clinical practice. Report symptoms such as burning, urgency, or blood in the urine promptly.

7) Can I drink alcohol while on cyclophosphamide?

It’s generally advised to avoid or limit alcohol due to added risk of dehydration, liver-related effects, and increased side effects. Discuss what is safest for you with your clinician.

8) What are the most serious side effects to watch for?

The most important are infection due to low white blood cells, bleeding due to low platelets, and urinary bladder irritation (including blood in urine). Fever or symptoms of infection should be treated urgently.

9) Will cyclophosphamide affect fertility?

It can. Fertility effects vary based on dose, treatment schedule, and individual factors. If fertility preservation is important to you, discuss options early with your healthcare team.

10) What are common drug interactions?

Interactions may occur with medicines that affect the liver, kidney function, or bone marrow suppression. Always provide your pharmacist with a complete list of medicines (including over-the-counter products and herbal supplements).


If you have questions about your specific treatment schedule, side effects, or how to take cyclophosphamide safely, speak with your pharmacist or treating specialist. They can tailor guidance to your diagnosis, blood test results, and the exact product you have been given.

Additional information

Dosage: No selection

50mg

Package: No selection

30 pill, 60 pill, 90 pill, 120 pill, 180 pill, 360 pill